グリコミクスまたは糖鎖生物学の世界市場レポート 2025年

グリコミクスまたは糖鎖生物学の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR17.2％で40億3,000万米ドルに成長します。予測期間の成長は、グリカンに特化した人工知能（AI）とデータ分析、糖鎖生物学をベースとした医薬品開発の拡大、疾患バイオマーカー探索におけるグリコミクスの統合、個別化医療、グリカンをベースとした治療法に起因します。予測期間における主な動向としては、学際的な共同研究、疾患メカニズムにおけるグリコシル化パターン、革新的な精密医療と個別化治療、糖鎖分析ツールの進歩、免疫療法とワクチンにおけるグリカンなどが挙げられます。

重篤な慢性疾患に対応する医薬品に対する需要の急増は、グリコミクスまたは糖鎖生物学市場の成長を促進する見通しです。慢性疾患は、決定的な治療法がないまま長期にわたって持続するため、これらの疾患に対する薬剤開発における糖鎖の変化とその機能的な意味を理解するために、グリコミクスに関する広範な研究が必要となります。米国がん協会のCancer Facts and Figures 2022-2024によると、慢性疾患とされるがんの生存者数は、2032年の2,250万人から2040年には推定2,600万人に増加すると予測されています。したがって、重篤な慢性疾患の治療薬に対する需要の高まりは、グリコミクスまたは糖鎖生物学市場の重要な促進要因となっています。

医薬品に対するニーズの高まりは、グリコミクスまたは糖鎖生物学市場の成長の主要な促進要因になると予想されます。これらの製品には、さまざまな病状を診断、予防、治療、治癒するために特別に処方された医薬品が含まれます。グリコミクスと糖鎖生物学は、疾病メカニズムの解明、治療標的の特定、薬剤設計と効果の最適化など、医薬品開発において重要な役割を果たしています。欧州製薬団体連合会（EFPIA）によると、2022年の欧州の医薬品総生産額は3,842億米ドル（3,400億ユーロ）に急増し、前年の3,662億6,700万米ドル（3,239億5,000万ユーロ）から4.95％の大幅増となりました。その結果、医薬品に対する需要の高まりが、グリコミクスまたは糖鎖生物学市場の成長を後押しする触媒として機能しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のグリコミクスまたは糖鎖生物学市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のグリコミクスまたは糖鎖生物学市場：成長率分析
• 世界のグリコミクスまたは糖鎖生物学市場の実績：規模と成長、2019～2024年
• 世界のグリコミクスまたは糖鎖生物学市場の予測：規模と成長、2024～2029年、2034年
• 世界のグリコミクスまたは糖鎖生物学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のグリコミクスまたは糖鎖生物学市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 酵素
• キット
• 試薬および化学薬品
• 機器
• 糖質
• 世界のグリコミクスまたは糖鎖生物学市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 創薬・開発
• 病気の診断
• その他
• 世界のグリコミクスまたは糖鎖生物学市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 学術研究機関
• 製薬・バイオテクノロジー企業
• 臨床検査室
• 世界のグリコミクスまたは糖鎖生物学市場：酵素のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• グリコシダーゼ
• グリコシルトランスフェラーゼ
• シアリダーゼ
• 世界のグリコミクスまたは糖鎖生物学市場：キットのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• グリカン分析キット
• 糖鎖生物学研究キット
• 世界のグリコミクスまたは糖鎖生物学市場：試薬および化学薬品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 単糖類
• オリゴ糖
• 化学修飾剤
• 世界のグリコミクスまたは糖鎖生物学市場：機器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 質量分析計
• クロマトグラフィーシステム
• 画像システム
• 世界のグリコミクスまたは糖鎖生物学市場：糖質のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 天然糖質
• 合成糖質

第7章 地域別・国別分析

• 世界のグリコミクスまたは糖鎖生物学市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のグリコミクスまたは糖鎖生物学市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• グリコミクスまたは糖鎖生物学市場：競合情勢
• グリコミクスまたは糖鎖生物学市場：企業プロファイル
  • Aligent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck Co. & KgaA Overview, Products and Services, Strategy and Financial Analysis
  • New England Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Shimadzu Corporation
• ProZyme Inc.
• Takara Bio Inc.
• Asparia Glycomics SL
• Lectenz Bio
• Chemily Glycoscience LLC
• Z Biotech LLC
• RayBiotech Inc.
• Thermo Fisher Scientific Inc.
• Promega Corporation
• Bio-Techne Corp.
• AMS Bio LLC
• Ludger Ltd.
• CD BioGlyco Ltd.
• GlycoDiag SAS

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• グリコミクスまたは糖鎖生物学市場2029年：新たな機会を提供する国
• グリコミクスまたは糖鎖生物学市場2029年：新たな機会を提供するセグメント
• グリコミクスまたは糖鎖生物学市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Glycomics or glycobiology encompasses the exploration of saccharides' structures, biosynthesis, and biological functions, delving into the intricate world of sugar chains or glycans widely present in natural systems. These glycans are thoroughly examined within the realm of glycobiology for their structural composition, production processes, and biological significance.

The primary products associated with glycomics or glycobiology include enzymes, kits, reagents and chemicals, instruments, and carbohydrates. Enzymes, as biological polymers, serve as catalysts for biochemical reactions. These products find application across various domains such as drug discovery and development, disease diagnostics, among others, and are extensively utilized within academic research institutes, pharmaceutical and biotechnology companies, as well as clinical laboratories.

The glycomics or glycobiology market research report is one of a series of new reports from The Business Research Company that provides glycomics or glycobiology market statistics, including glycomics or glycobiology industry global market size, regional shares, competitors with a glycomics or glycobiology market share, detailed glycomics or glycobiology market segments, market trends and opportunities, and any further data you may need to thrive in the glycomics or glycobiology industry. This glycomics or glycobiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification.

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $4.03 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (ai) and data analytics, expansion in glycobiology-based drug development, integration of glycomics in disease biomarker discovery, personalized medicine, and glycan-based therapeutics. Major trends in the forecast period include cross-disciplinary collaborations, glycosylation patterns in disease mechanisms, innovative precision medicine and personalized therapies, advancements in glycoanalytical tools, glycans in immunotherapy and vaccines.

The surge in demand for medications catering to severe chronic diseases is poised to drive the growth of the glycomics or glycobiology market. Chronic diseases, which persist over the long term without definitive cures, prompt extensive research into glycomics to understand glycosylation changes and their functional implications in drug development for these conditions. According to the American Cancer Society's Cancer Facts and Figures 2022-2024, the number of cancer survivors, considered a chronic disease, is projected to increase from 22.5 million in 2032 to an estimated 26 million by 2040. Hence, the escalating demand for medications to treat severe chronic diseases acts as a significant driver for the glycomics or glycobiology market.

The rising need for pharmaceutical products is expected to be a major driver for the growth of the glycomics or glycobiology market. These products encompass drugs specifically formulated to diagnose, prevent, treat, or cure various medical conditions. Glycomics and glycobiology play crucial roles in pharmaceutical development by elucidating disease mechanisms, identifying therapeutic targets, and optimizing drug design and effectiveness. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total pharmaceutical production in Europe surged to $384,200 million (€340,000 million) in 2022, marking a significant 4.95% increase from the preceding year's $366,267 million (€323,950 million). Consequently, the heightened demand for pharmaceutical products acts as a catalyst propelling the glycomics or glycobiology market's growth.

A prevailing trend in the glycomics or glycobiology market is the emphasis on investments in research and development (R&D) endeavors. Prominent research institutions are channeling funding into glycobiology research centers, aiming to further advancements in glycomics or glycobiology. For instance, Griffith University's Institute for Glycomics unveiled the ACRF International center for Cancer Glycomics in August 2022. This pioneering facility, established with a $2.6 million ACRF grant, is dedicated to unraveling cancer glycocoding. It is envisioned as a unique resource, driving enhanced understanding of the glycocode and translating discoveries into clinical outcomes, ultimately improving the lives of cancer patients.

Leading companies within the glycomics or glycobiology market are innovating by developing cutting-edge products like glycan screening kits to cater to expanded customer bases and augment revenue streams. Glycan Screening Kits are specialized tools designed for comprehensive immunofluorescence detection of glycan expression in tissue sections, aiding researchers in characterizing complex glycans for insights into disease biomarkers and protein modifications. Vector Laboratories Inc., in July 2022, introduced its breakthrough product, the Glysite Scout Glycan Screening Kits. These fully integrated immunofluorescence kits offer robust capabilities for profiling glycan expression in tissue sections. The kits empower researchers to gain valuable insights into the significance of glycomics in samples, particularly in understanding post-translational protein modifications and disease biomarkers. With curated lectin selections, these kits enable the identification of major surface glycan motifs, enriching the understanding of disease progression, treatment impacts, and tissue characterization.

In October 2022, the Centre for Cellular and Molecular Platforms (C-CAMP), an India-based research foundation, entered into a partnership with Agilent Technologies, Inc. for an undisclosed amount. Through this collaboration, C-CAMP aims to enhance its portfolio by leveraging Agilent's expertise in mass spectrometry-based characterization of biotherapeutics and biosimilars. Agilent Technologies Inc., a US-based company, is known for offering AdvanceBio glycoenzymes.

Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

North America was the largest region in the glycomics or glycobiology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glycomics or glycobiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glycomics or glycobiology market includes revenues earned by entities by maintaining tissue structure, porosity, and integrity. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glycomics or Glycobiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glycomics or glycobiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glycomics or glycobiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glycomics or glycobiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Enzymes; Kits; Reagents And Chemicals; Instruments; Carbohydrates
• 2) By Application: Drug Discovery And Development; Disease Diagnostics; Other Applications
• 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Clinical Laboratories
• Subsegments:
• 1) By Enzymes: Glycosidases; Glycosyltransferases; Sialidases
• 2) By Kits: Glycan Analysis Kits; Glycobiology Research Kits
• 3) By Reagents And Chemicals: Monosaccharides; Oligosaccharides; Chemical Modifiers
• 4) By Instruments: Mass Spectrometers; Chromatography Systems; Imaging Systems
• 5) By Carbohydrates: Natural Carbohydrates; Synthetic Carbohydrates
• Companies Mentioned: Aligent Technologies Inc.; Bruker Corporation; Merck Co. & KgaA; New England Biolabs Inc.; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glycomics or Glycobiology Market Characteristics

3. Glycomics or Glycobiology Market Trends And Strategies

4. Glycomics or Glycobiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Glycomics or Glycobiology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Glycomics or Glycobiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Glycomics or Glycobiology Market Growth Rate Analysis
• 5.4. Global Glycomics or Glycobiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Glycomics or Glycobiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Glycomics or Glycobiology Total Addressable Market (TAM)

6. Glycomics or Glycobiology Market Segmentation

• 6.1. Global Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Kits
• Reagents and Chemicals
• Instruments
• Carbohydrates
• 6.2. Global Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery and Development
• Disease Diagnostics
• Other Applications
• 6.3. Global Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic Research Institutes
• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• 6.4. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glycosidases
• Glycosyltransferases
• Sialidases
• 6.5. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glycan Analysis Kits
• Glycobiology Research Kits
• 6.6. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Reagents And Chemicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monosaccharides
• Oligosaccharides
• Chemical Modifiers
• 6.7. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mass Spectrometers
• Chromatography Systems
• Imaging Systems
• 6.8. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Carbohydrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Carbohydrates
• Synthetic Carbohydrates

7. Glycomics or Glycobiology Market Regional And Country Analysis

• 7.1. Global Glycomics or Glycobiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Glycomics or Glycobiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glycomics or Glycobiology Market

• 8.1. Asia-Pacific Glycomics or Glycobiology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glycomics or Glycobiology Market

• 9.1. China Glycomics or Glycobiology Market Overview
• 9.2. China Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glycomics or Glycobiology Market

• 10.1. India Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glycomics or Glycobiology Market

• 11.1. Japan Glycomics or Glycobiology Market Overview
• 11.2. Japan Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glycomics or Glycobiology Market

• 12.1. Australia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glycomics or Glycobiology Market

• 13.1. Indonesia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glycomics or Glycobiology Market

• 14.1. South Korea Glycomics or Glycobiology Market Overview
• 14.2. South Korea Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glycomics or Glycobiology Market

• 15.1. Western Europe Glycomics or Glycobiology Market Overview
• 15.2. Western Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glycomics or Glycobiology Market

• 16.1. UK Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glycomics or Glycobiology Market

• 17.1. Germany Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glycomics or Glycobiology Market

• 18.1. France Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glycomics or Glycobiology Market

• 19.1. Italy Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glycomics or Glycobiology Market

• 20.1. Spain Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glycomics or Glycobiology Market

• 21.1. Eastern Europe Glycomics or Glycobiology Market Overview
• 21.2. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glycomics or Glycobiology Market

• 22.1. Russia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glycomics or Glycobiology Market

• 23.1. North America Glycomics or Glycobiology Market Overview
• 23.2. North America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glycomics or Glycobiology Market

• 24.1. USA Glycomics or Glycobiology Market Overview
• 24.2. USA Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glycomics or Glycobiology Market

• 25.1. Canada Glycomics or Glycobiology Market Overview
• 25.2. Canada Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glycomics or Glycobiology Market

• 26.1. South America Glycomics or Glycobiology Market Overview
• 26.2. South America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glycomics or Glycobiology Market

• 27.1. Brazil Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glycomics or Glycobiology Market

• 28.1. Middle East Glycomics or Glycobiology Market Overview
• 28.2. Middle East Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glycomics or Glycobiology Market

• 29.1. Africa Glycomics or Glycobiology Market Overview
• 29.2. Africa Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glycomics or Glycobiology Market Competitive Landscape And Company Profiles

• 30.1. Glycomics or Glycobiology Market Competitive Landscape
• 30.2. Glycomics or Glycobiology Market Company Profiles
  • 30.2.1. Aligent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck Co. & KgaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. New England Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Glycomics or Glycobiology Market Other Major And Innovative Companies

• 31.1. Shimadzu Corporation
• 31.2. ProZyme Inc.
• 31.3. Takara Bio Inc.
• 31.4. Asparia Glycomics SL
• 31.5. Lectenz Bio
• 31.6. Chemily Glycoscience LLC
• 31.7. Z Biotech LLC
• 31.8. RayBiotech Inc.
• 31.9. Thermo Fisher Scientific Inc.
• 31.10. Promega Corporation
• 31.11. Bio-Techne Corp.
• 31.12. AMS Bio LLC
• 31.13. Ludger Ltd.
• 31.14. CD BioGlyco Ltd.
• 31.15. GlycoDiag SAS

32. Global Glycomics or Glycobiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glycomics or Glycobiology Market

34. Recent Developments In The Glycomics or Glycobiology Market

35. Glycomics or Glycobiology Market High Potential Countries, Segments and Strategies

• 35.1 Glycomics or Glycobiology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Glycomics or Glycobiology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Glycomics or Glycobiology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer